NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,703,624 | +19.4% | 281,795 | +18.3% | 0.91% | +13.2% |
| Q2 2023 | $24,041,618 | +106.5% | 238,248 | +88.3% | 0.80% | +81.7% |
| Q1 2023 | $11,640,682 | +13.9% | 126,529 | +12.3% | 0.44% | +0.5% |
| Q4 2022 | $10,222,470 | +26.9% | 112,682 | +6.3% | 0.44% | +15.5% |
| Q3 2022 | $8,057,000 | -1.5% | 106,000 | +9.5% | 0.38% | +2.4% |
| Q2 2022 | $8,182,000 | +13.1% | 96,791 | +17.4% | 0.37% | +15.9% |
| Q1 2022 | $7,236,000 | +12.8% | 82,458 | +12.4% | 0.32% | +19.3% |
| Q4 2021 | $6,417,000 | +14.7% | 73,364 | +7.2% | 0.27% | -19.2% |
| Q3 2021 | $5,597,000 | -6.6% | 68,440 | +4.2% | 0.33% | -27.3% |
| Q2 2021 | $5,991,000 | +18.1% | 65,658 | +10.7% | 0.46% | -9.1% |
| Q1 2021 | $5,071,000 | +208.8% | 59,320 | +241.1% | 0.50% | -0.2% |
| Q4 2020 | $1,642,000 | – | 17,391 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |